/ database / Growth Hormone Releasing Hormone Analog

CJC-1295 (no DAC)

Also: MOD GRF 1-29 · Modified GRF

GHRH partner to Ipamorelin — together they amplify the GH pulse.

Evidence
emerging
Legal status
research only
Half-life
~30 min (no DAC)
Routes
subq
What it is

CJC-1295 without DAC is a short-acting GHRH analog typically paired with a GHRP like Ipamorelin to create a much larger, but still physiological, GH pulse. The DAC version stays in circulation longer and is considered less physiological.

Mechanism

A GHRH analog that extends the duration of GH release. The no-DAC variant is short-acting and pulse-friendly.

Outcomes it's matched to
Safety

Well tolerated when used physiologically.

  • Active cancer
  • Pregnancy
Legal context

Not approved for human use.

1:1 GUIDANCE

Have questions about this peptide?

Get free 1:1 guidance from a peptide professional before you start. They'll help you think through dosing, stacking, and whether this fits your goals.

REQUEST A CALL →
PepVault

An outcome-driven reference for modern peptides. Educational only — not medical advice, not a sales platform, not affiliated with any clinic.

Disclaimer: PepVault is an educational resource. Nothing on this site is medical advice. Many peptides discussed are research compounds and are not approved by the FDA or equivalent agencies. Always consult a qualified clinician before starting any protocol.

© 2026 PepVault